Skip to content

SCHEDULE 13D/AAccepted May 28, 5:24 PM ET

Outlook Therapeutics, Inc. SCHEDULE 13D/A

GMS Ventures & Investments

Accepted (ET)

5:24 PM

May 28, 2025

Filed

May 28, 2025

Documents

2

Size

20.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.